Purchases and Sales Made in Q3 2023 in Belite Bio, Inc (BLTE)
This table provides information about the institutional ownership of Belite Bio, Inc (BLTE) during Q3 2023. The information is specifically focused on institutions that hold shares of BELITE BIO, INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
6.7KNew |
$84K - $245K
|
6.7K
$555K
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
3.58K+ 26.75% |
$44.9K - $131K
|
17K
$1.4M
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
BUY
|
- |
583+ 194.33% |
$7.3K - $21.4K
|
883
$73.1K
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
525New |
$6.58K - $19.2K
|
525
$43.5K
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 08, 2023
Q3 2023
|
Atria Wealth Solutions, Inc.
New York, NY |
SELL
|
- |
-740K- 90.91% |
$9.28M - $27.1M
|
74K
$6.13M
|